Back to top

BioNTech SE (BNTX) Receives a Buy from Morgan Stanley

In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on BioNTech SE, with a price target of $115.00. According to ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

BioNTech SE Sponsored ADR (BNTX)